CurrentCardio
Get Weekly

Topic · page 10 of 18

Valvular & structural heart disease

Aortic, mitral and tricuspid disease, TAVI/TEER, surgical valve therapy, PFO/LAA closure

Briefs 361–400 of 696 placed here, newest publication first

Briefs in Valvular & structural heart disease

Newest publication first

  1. Eur Heart J

    Artificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international study

    Diagnostic or prognostic study

  2. JACC Cardiovasc Interv

    Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry

    Cohort study

  3. J Am Coll Cardiol

    3-Year Clinical Outcomes Comparing the Amulet vs Watchman FLX for Left Atrial Appendage Closure in Patients With Atrial Fibrillation: Results From the SWISS-APERO Randomized Clinical Trial

    Randomised controlled trial

  4. JACC Cardiovasc Imaging

    Nonischemic Septal Fibrosis in Functional Tricuspid Regurgitation Provides Incremental Stratification of Adverse Remodeling and Prognosis

    Cohort study

  5. Eur Heart J

    Carbon emission analysis of aortic valve replacement: the environmental footprint of transcatheter vs. surgical procedures

    Research article

  6. JACC Heart Fail

    Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation With Extended Non–COAPT-Like Features: From the EXPANDed Studies

    Secondary analysis

  7. J Am Coll Cardiol

    1-Year Results From a Multicenter Trial of a Polymer Surgical Mitral Valve: Insights Into New Technology

    Cohort study

  8. J Am Coll Cardiol

    Aortic Stenosis and Mitral Regurgitation: Takeaways From the Heart Valve Collaboratory Workshop on Multivalvular Disease

    Guideline or statement

  9. Eur Heart J

    Urgent surgery vs fibrinolytic therapy for left-sided prosthetic valve thrombosis: a randomized trial

    Randomised controlled trial

  10. JACC Cardiovasc Interv

    CT and Fluoroscopic Analyses of Valve Expansion in Redo-TAVR: A First-in-Human Report

    Cohort study

  11. JACC Cardiovasc Interv

    30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum Study

    Cohort study

  12. JACC Cardiovasc Interv

    Transcatheter Edge-to-Edge Repair for Atrial and Ventricular Secondary Mitral Regurgitation: Insights From the REPAIR Study

    Cohort study

  13. JACC Cardiovasc Interv

    Early Outcomes of Real-World Transcatheter Tricuspid Valve Replacement

    Cohort study

  14. JACC Cardiovasc Interv

    Prosthesis-Patient Mismatch in Young and Low-Risk Patients After Newer Generation Balloon-Expandable Transcatheter Aortic Valve Replacement

    Cohort study

  15. JACC Cardiovasc Interv

    The Coronary Access After TAVI (CAvEAT) Study: A Prospective Registry of CA After TAVR

    Cohort study

  16. JACC Cardiovasc Interv

    15-Year Outcomes of PFO Closure in Patients With Cryptogenic Embolism: Insights From the PROLONG Registry

    Cohort study

  17. JACC Cardiovasc Interv

    Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

    Meta-analysis

  18. Eur J Prev Cardiol

    Hyperglycaemia and genetic susceptibility in relation to incident degenerative aortic valve stenosis

    Cohort study

  19. Eur J Heart Fail

    Prognostic Value of NT-ProBNP in Patients with Primary Mitral Regurgitation Undergoing Transcatheter Edge-To-Edge Repair

    Cohort study

  20. J Am Coll Cardiol

    Cardiac Computed Tomography for Prosthetic Heart Valve Assessment: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the European Society of Cardiovascular Radiology (ESCR), the North American Society of Cardiovascular Imaging (NASCI), the Radiological Society of North America (RSNA), the Society for Cardiovascular Angiography & Interventions (SCAI) and Society of Thoracic Surgeons (STS)

    Guideline or statement

  21. JACC Cardiovasc Interv

    Ventricular Interaction and Clinical Outcomes in Patients Undergoing Transcatheter Tricuspid Valve Repair

    Cohort study

  22. JACC Cardiovasc Interv

    Heterotopic Crosscaval Transcatheter Tricuspid Valve Replacement for Patients With Tricuspid Regurgitation: The Trillium Device

    Research article

  23. JACC Cardiovasc Interv

    Right Ventricular–Pulmonary Artery Coupling in Tricuspid Regurgitation: Prognostic Value and Impact of Treatment Strategy

    Cohort study

  24. JACC Cardiovasc Interv

    Tricuspid Regurgitation and 3-Year Mortality After Transseptal Mitral Valve-in-Valve Replacement

    Cohort study

  25. JACC Cardiovasc Interv

    3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United States

    Cohort study

  26. Eur J Heart Fail

    Employment of Artificial Intelligence for an Unbiased Evaluation Regarding the Recovery of Right Ventricular Function after Mitral Valve Transcatheter Edge-to-Edge Repair

    Cohort study

  27. Eur Heart J

    Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis

    Cohort study

  28. JAMA Cardiol

    Automated Deep Learning Phenotyping of Tricuspid Regurgitation in Echocardiography

    Diagnostic or prognostic study

  29. JACC Cardiovasc Interv

    Transcatheter Edge-to-Edge Repair in Patients With Primary Tricuspid Regurgitation

    Cohort study

  30. Lancet

    ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial

    Randomised controlled trial

  31. Eur J Prev Cardiol

    Associations between sweetened beverage consumption, degenerative valvular heart disease, and related events: a prospective study from UK Biobank

    Cohort study

  32. Eur J Prev Cardiol

    High Life’s Essential 8 score is associated with lower aortic valve calcification

    Cross-sectional study

  33. JACC Cardiovasc Interv

    Intravascular Ultrasound Assessment of Coronary Arteries at High Risk for Obstruction Following TAVR: The ICARO Study

    Cohort study

  34. JACC Cardiovasc Interv

    Risk of Coronary Obstruction in Redo-Transcatheter Aortic Valve Replacement Between Bicuspid and Tricuspid Aortic Valves

    Research article

  35. JACC Cardiovasc Interv

    Transcatheter Aortic Valve Replacement With Intra-Annular Self-Expanding or Balloon-Expandable Valves: The Multicenter International NAVULTRA Registry

    Cohort study

  36. Eur J Heart Fail

    Aetiological Phenotypes of Atrial and Ventricular Secondary Tricuspid Regurgitation and Their Prognostic Implications: Insights from the CARE-TR Registry

    Cohort study

  37. JACC Cardiovasc Interv

    Clinical Impact of Midframe Underexpansion Following TAVR Using a Self-Expanding Transcatheter Heart Valve

    Cohort study

  38. Eur Heart J

    Blood biomarkers in left-sided valvular heart disease

    Research article

  39. JACC Cardiovasc Imaging

    5-Year Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients

    Secondary analysis

  40. Eur Heart J

    Pregnancy with a prosthetic heart valve, thrombosis, and bleeding: the ESC EORP Registry of Pregnancy and Cardiac disease III

    Cohort study

All 696 Briefs in ExploreShowing Briefs 361–400 of 696, newest first